How to Read a Balance Sheet Like an Analyst
Analysts do not treat the balance sheet as a static accounting formality. They read it as a record of decisions, […]
Long Term Value Investor Analysis of Cogeco Communications (CCA)
2026-02-02 Cogeco Communication CCA.TO provides high speed Internet to residential and business customers. It is a mature, asset heavy Canadian
Long-Term Value Investor Analysis of Bridgemarq Real Estate Services
2026-02-02 BRE.TO is a small Canadian publicly listed operating business that offers tools, information, and services to help real estate
Long-Term Value Investor Analysis of American Express (AXP)
2026-02-01 American Express operates a global payments network focused on affluent consumers and premium corporate clients. Unlike Visa and Mastercard,
Shopify: A High-Quality Platform with a Venture Capital Valuation
2026-01-31 Shopify provides software and infrastructure that allow merchants of all sizes to build, operate, and scale online businesses. It
Long-Term Value Investor Analysis of Royal Bank of Canada (RY.TO)
Royal Bank of Canada is the country’s largest financial institution, spanning personal banking, commercial lending, capital markets, wealth management, and
EU-India Free Trade Deal of 2026 Explained
The European Union and the Republic of India have signed a long-anticipated Free Trade Agreement, widely described by leaders on
Kinder Morgan (KMI) Under the Microscope: A Value Investor’s Long View on Cash Flows, Moats, and Margin of Safety
2026-01-27 Kinder Morgan is one of North America’s largest energy infrastructure companies, owning and operating natural gas pipelines, refined product
What will happen if Trump imposes 100% tariff on Canadian Imports
The United States and Canada maintain one of the world’s most extensive and deeply integrated trading relationships. In 2024, bilateral
Long-Term Value Investor Analysis of Gilead Sciences (GILD)
Date: 2026-01-26 Gilead Sciences is a research driven biopharmaceutical company focused on antiviral medicines, oncology therapies, and treatments for inflammatory
Long-Term Value Investor Analysis of Pfizer (PFE): High Dividend Value Play or Post Pandemic Trap?
2026-01-26 Pfizer is a global pharmaceutical company that develops, manufactures, and sells patented medicines and vaccines across oncology, immunology, cardiology,
Long-Term Value Investor Analysis of AbbVie (ABBV)
Date: 2026-01-24 AbbVie is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in immunology,